Amy Berrington de González

Abstract B055: Racial and ethnic disparities in the risk of contralateral breast cancer among primary breast cancer survivors in the US (1992-2023)

Breast cancer survivors have an increased risk of developing contralateral breast cancer (CBC), with approximately 1 in 30 developing CBC within 10 years of their initial diagnosis. However, few U.S. studies have examined CBC risk by racial and ethnic differences or by estrogen receptor (ER) subtype of the contra...

Abstract A122: Breast cancer differences in incidence-based mortality by subtype, race and ethnicity, county-level population density, and median household income in the US, 2000-2023

Black women had consistently high ER+ and ER- breast cancer incidence-based MRs compared with all racial and ethnic groups regardless of residence at diagnosis, and patterns were largely consistent by county-level population density and income for racial and ethnic groups.

Trends in U.S. breast cancer mortality by estrogen receptor status.

Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial.

Proton RT generally conferred significantly lower doses to the heart and cardiac substructures compared with photon RT, and PRO-CTCAE measures were favorable overall.

Breast density and risk factors for interval and screen-detected breast cancers: a case–case analysis of the Breast Cancer Now Generations Study, UK

Higher breast density was associated with later age at menarche, nulliparity, breastfeeding, history of benign breast disease, alcohol consumption, lower body mass index (BMI) at recruitment and at age 20, and current use of menopausal hormone therapy (MHT).

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

This pooled analysis of 15,731 cases showed that nulliparity, age at menopause, MHT, and BMI have independent, dose-response associations with ER, PR, and grade, clarifying patterns of etiologic heterogeneity.